279 related articles for article (PubMed ID: 15822043)
21. No Benefit of Oral Diclofenac on Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis.
Ishiwatari H; Urata T; Yasuda I; Matsusaki S; Hisai H; Kawakami H; Ono M; Iwashita T; Doi S; Kawakubo K; Hayashi T; Sonoda T; Sakamoto N; Kato J
Dig Dis Sci; 2016 Nov; 61(11):3292-3301. PubMed ID: 27447477
[TBL] [Abstract][Full Text] [Related]
22. Preventive effect of ulinastatin and gabexate mesylate on post-endoscopic retrograde cholangiopancreatography pancreatitis.
Zhang ZF; Yang N; Zhao G; Zhu L; Zhu Y; Wang LX
Chin Med J (Engl); 2010 Sep; 123(18):2600-6. PubMed ID: 21034635
[TBL] [Abstract][Full Text] [Related]
23. High-dose allopurinol for prevention of post-ERCP pancreatitis: a prospective randomized double-blind controlled trial.
Katsinelos P; Kountouras J; Chatzis J; Christodoulou K; Paroutoglou G; Mimidis K; Beltsis A; Zavos C
Gastrointest Endosc; 2005 Mar; 61(3):407-15. PubMed ID: 15758912
[TBL] [Abstract][Full Text] [Related]
24. Oral udenafil and aceclofenac for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis in high-risk patients: a randomized multicenter study.
Lee TY; Choi JS; Oh HC; Song TJ; Do JH; Cheon YK
Korean J Intern Med; 2015 Sep; 30(5):602-9. PubMed ID: 26354054
[TBL] [Abstract][Full Text] [Related]
25. Interleukin 10 reduces the incidence of pancreatitis after therapeutic endoscopic retrograde cholangiopancreatography.
Devière J; Le Moine O; Van Laethem JL; Eisendrath P; Ghilain A; Severs N; Cohard M
Gastroenterology; 2001 Feb; 120(2):498-505. PubMed ID: 11159890
[TBL] [Abstract][Full Text] [Related]
26. Somatostatin for prevention of post-ERCP pancreatitis: a randomized, double-blind trial.
Concepción-Martín M; Gómez-Oliva C; Juanes A; Díez X; Prieto-Alhambra D; Torras X; Sainz S; Villanueva C; Farre A; Guarner-Argente C; Guarner C
Endoscopy; 2014 Oct; 46(10):851-6. PubMed ID: 24977398
[TBL] [Abstract][Full Text] [Related]
27. Low-molecular-weight heparin does not prevent acute post-ERCP pancreatitis.
Rabenstein T; Fischer B; Wiessner V; Schmidt H; Radespiel-Tröger M; Hochberger J; Mühldorfer S; Nusko G; Messmann H; Schölmerich J; Schulz HJ; Schönekäs H; Hahn EG; Schneider HT
Gastrointest Endosc; 2004 May; 59(6):606-13. PubMed ID: 15114301
[TBL] [Abstract][Full Text] [Related]
28. The prophylactic effect of somatostatin on post-therapeutic endoscopic retrograde cholangiopancreatography pancreatitis: a randomized, multicenter controlled trial.
Lee KT; Lee DH; Yoo BM
Pancreas; 2008 Nov; 37(4):445-8. PubMed ID: 18953260
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of postprocedure administration of gabexate mesylate in the prevention of post-ERCP pancreatitis: a randomized, controlled, multicenter study.
Manes G; Ardizzone S; Lombardi G; Uomo G; Pieramico O; Porro GB
Gastrointest Endosc; 2007 Jun; 65(7):982-7. PubMed ID: 17531632
[TBL] [Abstract][Full Text] [Related]
30. Intravenous N-acetylcysteine does not prevent post-ERCP pancreatitis.
Katsinelos P; Kountouras J; Paroutoglou G; Beltsis A; Mimidis K; Zavos C
Gastrointest Endosc; 2005 Jul; 62(1):105-11. PubMed ID: 15990827
[TBL] [Abstract][Full Text] [Related]
31. Can somatostatin prevent post-ERCP pancreatitis? Results of a randomized controlled trial.
Arvanitidis D; Anagnostopoulos GK; Giannopoulos D; Pantes A; Agaritsi R; Margantinis G; Tsiakos S; Sakorafas G; Kostopoulos P
J Gastroenterol Hepatol; 2004 Mar; 19(3):278-82. PubMed ID: 14748874
[TBL] [Abstract][Full Text] [Related]
32. Diclofenac sodium versus ceftazidime for preventing pancreatitis after endoscopic retrograde cholangiopancreatography: a prospective, randomized, controlled trial.
Hauser G; Blažević I; Salkić N; Poropat G; Giljača V; Bulić Z; Štimac D
Surg Endosc; 2017 Feb; 31(2):602-610. PubMed ID: 27317032
[TBL] [Abstract][Full Text] [Related]
33. Risk factors for post-ERCP pancreatitis: a prospective multicenter study.
Cheng CL; Sherman S; Watkins JL; Barnett J; Freeman M; Geenen J; Ryan M; Parker H; Frakes JT; Fogel EL; Silverman WB; Dua KS; Aliperti G; Yakshe P; Uzer M; Jones W; Goff J; Lazzell-Pannell L; Rashdan A; Temkit M; Lehman GA
Am J Gastroenterol; 2006 Jan; 101(1):139-47. PubMed ID: 16405547
[TBL] [Abstract][Full Text] [Related]
34. Clinical trial of gabexate in the prophylaxis of post-endoscopic retrograde cholangiopancreatography pancreatitis.
Xiong GS; Wu SM; Zhang XW; Ge ZZ
Braz J Med Biol Res; 2006 Jan; 39(1):85-90. PubMed ID: 16400468
[TBL] [Abstract][Full Text] [Related]
35. Combination of diclofenac plus somatostatin in the prevention of post-ERCP pancreatitis: a randomized, double-blind, placebo-controlled trial.
Katsinelos P; Fasoulas K; Paroutoglou G; Chatzimavroudis G; Beltsis A; Terzoudis S; Katsinelos T; Dimou E; Zavos C; Kaltsa A; Kountouras J
Endoscopy; 2012 Jan; 44(1):53-9. PubMed ID: 22198776
[TBL] [Abstract][Full Text] [Related]
36. Randomized clinical trial to assess the efficacy of ulinastatin for postoperative pancreatitis following pancreaticoduodenectomy.
Uemura K; Murakami Y; Hayashidani Y; Sudo T; Hashimoto Y; Ohge H; Sueda T
J Surg Oncol; 2008 Oct; 98(5):309-13. PubMed ID: 18548482
[TBL] [Abstract][Full Text] [Related]
37. Prophylaxis of ERCP-related pancreatitis: a randomized, controlled trial of somatostatin and gabexate mesylate.
Andriulli A; Solmi L; Loperfido S; Leo P; Festa V; Belmonte A; Spirito F; Silla M; Forte G; Terruzzi V; Marenco G; Ciliberto E; Sabatino A; Monica F; Magnolia MR; Perri F
Clin Gastroenterol Hepatol; 2004 Aug; 2(8):713-8. PubMed ID: 15290665
[TBL] [Abstract][Full Text] [Related]
38. Prophylactic effect of somatostatin on post-ERCP pancreatitis: a randomized controlled trial.
Poon RT; Yeung C; Lo CM; Yuen WK; Liu CL; Fan ST
Gastrointest Endosc; 1999 May; 49(5):593-8. PubMed ID: 10228257
[TBL] [Abstract][Full Text] [Related]
39. Rectal indomethacin versus placebo to reduce the incidence of pancreatitis after endoscopic retrograde cholangiopancreatography: results of a controlled clinical trial.
Andrade-Dávila VF; Chávez-Tostado M; Dávalos-Cobián C; García-Correa J; Montaño-Loza A; Fuentes-Orozco C; Macías-Amezcua MD; García-Rentería J; Rendón-Félix J; Cortés-Lares JA; Ambriz-González G; Cortés-Flores AO; Alvarez-Villaseñor Adel S; González-Ojeda A
BMC Gastroenterol; 2015 Jul; 15():85. PubMed ID: 26195123
[TBL] [Abstract][Full Text] [Related]
40. Prospective randomized trial of the effect of nifedipine on pancreatic irritation after endoscopic retrograde cholangiopancreatography.
Sand J; Nordback I
Digestion; 1993; 54(2):105-11. PubMed ID: 8319838
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
